Scarica l'app Stockscreener
70.94
2.83%
1.98
Dopo l'orario di chiusura:
70.95
0.01
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Astrazeneca PLC Borsa (AZN) Ultime notizie
DEADLINE ALERT for KSPI, CPRI, AZN, RIG: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
AstraZeneca shareholders say they need clarity on China investigations - Reuters.com
Bank of England, AstraZeneca, Watches of Switzerland: Thursday ahead - Proactive Investors UK
Failed AstraZeneca deal is no way to sell Labour’s pro-growth ambitions - Financial Times
Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDAQ: AZN) - openPR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming DeadlinesAZN - PR Newswire
AstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Columbus Macro LLC Buys 12,454 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders - PR Newswire
Analysts recommendations: Shell, Deliveroo, Astrazeneca, Palantir, Tyson Foods... - Marketscreener.com
Koa Wealth Management LLC Has $2.02 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Golden State Equity Partners Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca (AZN) to Release Quarterly Earnings on Thursday - MarketBeat
AstraZeneca lung cancer therapy Imfinzi recommended for EU approval - Pharmaceutical Technology
AZN Stock News: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the AstraZeneca PLC Class Action - PR Newswire
Fifth Third Bancorp Sells 11,164 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Mediolanum International Funds Ltd Has $7.39 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - Markets Insider
AstraZeneca PLC ADR falls Monday, underperforms market - MarketWatch
AstraZeneca shareholders say they need clarity on China investigations -February 05, 2025 at 01:04 am EST - Marketscreener.com
AstraZeneca Plc to Host Earnings Call - ACCESS Newswire
AstraZeneca ramps up in Canada, cancels £450m Liverpool development - Cambridge Independent
AstraZeneca PLC Class Action: The Gross Law Firm Reminds - GlobeNewswire
AstraZeneca investment deal ‘didn’t add up for UK taxpayer’, says minister - Yahoo Finance UK
AstraZeneca Cut Vaccine R&D Pledge in Plant Funding Row, UK Says - Bloomberg
UK hits back at AstraZeneca over collapse of investment deal - Yahoo Finance UK
UK hits back at AstraZeneca over collapse of investment deal -February 03, 2025 at 12:05 pm EST - Marketscreener.com
AstraZeneca Announces Voting Rights Structure as of January 2025 - TipRanks
AstraZeneca Confirms Canceled UK Vaccines Plant, Reportedly Rejects GBP80 Million UK State Aid - Marketscreener.com
Seeking Clues to Astrazeneca (AZN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Astrazeneca Rejects Revised UK Government Support to Build Vaccine Plant in England - Marketscreener.com
AstraZeneca PLC (NASDAQ:AZN) Holdings Boosted by Jennison Associates LLC - MarketBeat
AstraZeneca's Imfinzi on track for EU approval in LS-SCLC treatment - Investing.com
AstraZeneca cancels £450m investment in UK after dispute over Government support - Yahoo Finance UK
Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant - BioProcess Insider
AstraZeneca: CHMP gives green light to Imfinzi in the EU -February 03, 2025 at 04:28 am EST - Marketscreener.com
Caprock Group LLC Purchases 3,600 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca dips after shelving UK investment plans - Proactive Investors USA
AstraZeneca's Imfinzi Wins EU Panel's Positive Opinion for Limited-stage Small Cell Lung Cancer - Marketscreener.com
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer - AstraZeneca
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC - GlobeNewswire
AstraZeneca PLC (LON:AZN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
AstraZeneca Stock Rally Will be Tested by Answers on China Probe - Bloomberg
AstraZeneca rejected close to £80mn in state support for cancelled Speke factory - Financial Times
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - The Malaysian Reserve
China Universal Asset Management Co. Ltd. Acquires 30,414 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Avantra Family Wealth Inc. Takes $596,000 Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Class Action Filed Against AstraZeneca PLC (AZN)February 21, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
AstraZeneca (AZN) Projected to Post Quarterly Earnings on Thursday - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Swedbank AB - MarketBeat
AstraZeneca cancels UK plant after subsidies cut - 台北時報
Nisa Investment Advisors LLC Lowers Position in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Orca Wealth Management LLC Takes $4.53 Million Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or - GlobeNewswire
Blue Trust Inc. Buys 7,686 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
2025-01-31 | AstraZeneca PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securitie - GuruFocus.com
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law Firm - Finansavisen
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):